Healthy Skepticism Library item: 12540

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Psaty BM, Korn D.
Congress responds to the IOM drug safety report--in full.
JAMA 2007 Nov 14; 298:(18):2185-7
http://jama.ama-assn.org/cgi/content/full/298/18/2185

Keywords:
Clinical Trials as Topic/legislation & jurisprudence Clinical Trials as Topic/standards* Conflict of Interest Databases, Factual Drug Approval/legislation & jurisprudence* Drug Toxicity* Institute of Medicine (U.S.) Pharmaceutical Preparations/adverse effects Politics Product Surveillance, Postmarketing* United States United States Food and Drug Administration*

Please
Click to Register

(read more)

then
Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts

If there is something you don't like, please tell us. If you like our work, please tell others.

Announcements

PharmedOut’s annual conference: Missing The Target: When Practitioners Harm More Than Heal

No Free Lunch is merging with Healthy Skepticism

Conference program: Pharma Knows Best? Managing Medical Knowledge

Prescrire’s proposals for France’s national conference on medicines policy

Pharmed Out Conference ‘Pharma Knows Best? Managing Medical Knowledge’

More announcements

What's new on this site

Library Home

Library Search

You are going to have many difficulties. The smokers will not like your message. The tobacco interests will be vigorously opposed. The media and the government will be loath to support these findings. But you have one factor in your favour. What you have going for you is that you are right.
- Evarts Graham
See:
When truth is unwelcome: the first reports on smoking and lung cancer.